)
)
)
AI in Clinical Development: Improving Trial Design and Evidence for Market Access
Gain a clear view of where AI is delivering measurable impact across clinical development and evidence generation and how these capabilities are influencing investment decisions, trial strategy, and commercial planning in women's health.
Discussion will focus on:
' How AI is being applied to improve trial design and patient stratification, including where it is reducing failure rates and delivering measurable impact on timelines and cost.
' How real-world data and AI are being used in regulatory and market access decisions, including what evidence is being accepted and where uncertainty remains.